NCT04566393 · Expanded access
Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies
Overall registry status Available
Conditions BRAF Gene Mutation, Bladder Cancer, Cholangiocarcinoma, Colorectal Cancer, ERK Mutation, Esophageal Cancer, Gastric Cancer, Glioblastoma, HRAS Gene Mutation, Head and Neck Cancer, Hepatocellular Carcinoma, KRAS Activating Mutation, MAPK Gene Mutation, MEK Mutation, Melanoma, NRAS Gene Mutation, Non Small Cell Lung Cancer, Ovarian Cancer, Pancreatic Cancer, Small Bowel Cancer, Thyroid Cancer
Delaware Valley sites
- The Minniti Center for Medical Oncology and Hematology · Mickleton, NJ · Gloucester County · Available
First posted
Registry updated
Added to the directory